Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Corrigan

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Seminars in Arthritis and Rheumatism|March 13, 2017
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) StudyJeffrey A Sparks, Medha Barbhaiya, Elizabeth W Karlson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 17, 2011
Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivityS M Rudman, D H Josephs, H Cambrook, et al.
Allergy|December 30, 2016
AllergoOncology - the impact of allergy in oncology: EAACI position paperE Jensen-Jarolim, H J Bax, R Bianchini, et al.
Allergy|February 17, 2023
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesisJ Bousquet, E Melén, T Haahtela, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Seminars in Arthritis and Rheumatism|March 13, 2017
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) StudyJeffrey A Sparks, Medha Barbhaiya, Elizabeth W Karlson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 17, 2011
Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivityS M Rudman, D H Josephs, H Cambrook, et al.
Allergy|December 30, 2016
AllergoOncology - the impact of allergy in oncology: EAACI position paperE Jensen-Jarolim, H J Bax, R Bianchini, et al.
Allergy|February 17, 2023
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesisJ Bousquet, E Melén, T Haahtela, et al.
Pageof 4